Chemycal has been acquired by 3E
Learn MoreDiscover how Chemycal PRO helps you boosting your regulatory monitoring:
(*) carbendazim for product-type 9 (fibre, leather, rubber and polymerised materials preservatives).
The committee’s opinion is that carbendazim, which meets the exclusion criteria, cannot be approved for product-type 9 because of unacceptable risks posed to the environment that cannot be mitigated.
Regarding the approval of two other active substances, the BPC requested the respective evaluating Member States to assess whether the active substances meet the new criteria for endocrine-disrupting properties before the committee adopts its opinions. The active substances are:
(*) Azamethiphos for product-type 18 (insecticides, acaricides and products to control other arthropods); and
(*) Epsilon-metofluthrin for product-type 19 (repellents and attractants).
The BPC also adopted positive opinions supporting Union authorisation for:
(*) two applications concerning biocidal product families based on iodine/PVP-iodine in product-type 3 (veterinary hygiene disinfectants); and
(*) three applications concerning biocidal product families based on
In addition, the committee adopted an opinion addressing a request from the European Commission on a dispute between
The Commission together with the EU Member States will take the final decision on the approval of the active substances and on the Union authorisation of biocidal products.
The committee met from 26 February to 1 March 2019. The opinions will be available on ECHA’s website in the near future. The next meeting will be held in June 2019.
CONTINUE READING ON echa.europa.eu
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions